Published in Acta Derm Venereol on July 01, 2010
Efficacy of 5% imiquimod cream in a patient with classic Kaposi sarcoma. J Dermatol Case Rep (2012) 0.77
Imiquimod - Its role in the treatment of cutaneous malignancies. Indian J Pharmacol (2015) 0.75
Dermoscopic changes in melanocytic naevi in children during digital follow-up. Acta Derm Venereol (2012) 1.99
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. J Clin Oncol (2006) 1.70
Skin cancer and other cutaneous disorders in liver transplant recipients. Acta Derm Venereol (2012) 1.41
Clinical and dermatoscopic fading of post-transplant eruptive melanocytic nevi after suspension of immunosuppressive therapy. J Am Acad Dermatol (2006) 1.22
Vohwinkel syndrome: treatment of pseudo-ainhum. Int J Dermatol (2010) 1.15
Immunosuppression and melanocyte proliferation. Melanoma Res (2009) 1.12
Bullous pemphigoid during long-term TNF-alpha blocker therapy. Dermatology (2009) 1.03
A case of malignant melanoma arising from an acquired agminated melanocytic naevus. Acta Derm Venereol (2007) 1.02
Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol (2004) 0.92
Primary cutaneous mantle cell lymphoma. Acta Derm Venereol (2011) 0.91
Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review. Acta Derm Venereol (2009) 0.87
Occurrence of squamous cell carcinoma in an area of lichen simplex chronicus: case report and pathogenetic hypothesis. J Cutan Med Surg (2012) 0.85
Targeting DSG3: from pemphigus to squamous cell carcinoma. Expert Opin Ther Targets (2013) 0.84
The role of immunohistochemical analysis in the diagnosis of parapsoriasis. Acta Histochem (2010) 0.84
Facial basal cell carcinoma: analysis of recurrence and follow-up strategies. Oncol Rep (2011) 0.83
Bullous scabies simulating pemphigoid. J Cutan Med Surg (2011) 0.83
Subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with absence of desmoglein 1 and 3 antibodies: case report and literature review. Am J Clin Dermatol (2008) 0.82
Effectiveness of different substrate materials for in vitro sunscreen tests. J Dermatol Sci (2009) 0.82
Nevus spilus and melanoma: case report and review of the literature. J Cutan Med Surg (2010) 0.81
Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up. Clin Dev Immunol (2009) 0.81
Large plaque type blue nevus with subcutaneous cellular nodules. Eur J Dermatol (2009) 0.81
Melanoma in skin affected with keratoderma palmoplantaris hereditaria (Mal de Meleda): Treatment with excision and grafting. J Am Acad Dermatol (2009) 0.81
Biochip technology for the serological diagnosis of bullous pemphigoid. ISRN Dermatol (2012) 0.81
Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions. Oncol Rep (2006) 0.80
Verrucous cutaneous sarcoidosis in an adolescent with dark skin. Eur J Dermatol (2010) 0.80
Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma. Cancer (2002) 0.79
Glutathione S-transferase and CYP1A1 gene polymorphisms and non-melanoma skin cancer risk in Italian transplanted patients. Exp Dermatol (2006) 0.79
C2 is superior to C0 as predictor of renal toxicity and rejection risk profile in stable heart transplant recipients. Transpl Int (2005) 0.79
Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controls. BMC Dermatol (2009) 0.78
Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation. Mutat Res (2009) 0.78
Sunscreen tests: correspondence between in vitro data and values reported by the manufacturers. J Dermatol Sci (2008) 0.78
Melanoma m (zero): diagnosis and therapy. ISRN Dermatol (2013) 0.78
Skin disorders in patients transplanted in childhood. Transpl Int (2005) 0.77
Non-alcoholic fatty liver disease, alcohol intake and psoriasis. J Hepatol (2010) 0.77
Melanoma m1: diagnosis and therapy. In Vivo (2014) 0.77
Erosive pustular dermatosis of the scalp induced by imiquimod. Case Rep Dermatol Med (2012) 0.77
In vitro evaluation of sunscreens: an update for the clinicians. ISRN Dermatol (2012) 0.77
Melanoma and immunosuppression. Dermatology (2008) 0.76
Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study. Thromb Haemost (2015) 0.76
Achromic superficial spreading melanoma accidentally treated with imiquimod. Acta Derm Venereol (2012) 0.76
γδ T cells as potential contributors to the progression of parapsoriasis to mycosis fungoides. Mol Med Rep (2011) 0.76
Erythroderma in the era of biological therapies. Eur J Dermatol (2012) 0.75
An unusual association between erosive hand osteoarthritis and morphea. Joint Bone Spine (2011) 0.75
Long-term Survival of Patients With Invasive Ultra-thin Cutaneous Melanoma: A Single-center Retrospective Analysis. Medicine (Baltimore) (2016) 0.75
Response to “change in dermoscopic pattern of naevi in children” by Scope et al. Acta Derm Venereol (2014) 0.75
Adaptive immune responses in primary cutaneous sarcoidosis. Clin Dev Immunol (2011) 0.75
Clinical and dermoscopic features of nevi in preschool children in Padua. Dermatology (2009) 0.75
Rejection-mediated regression of melanocytic naevi in an immunosuppressed organ transplant recipient. Acta Derm Venereol (2014) 0.75
High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma. J Am Acad Dermatol (2005) 0.75
Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo. J Dermatol Sci (2013) 0.75
Porokeratosis ptychotropica. Eur J Dermatol (2011) 0.75
Eczematous, Pruritic, Brownish Plaque of the Nipple and Areola: A Quiz. Acta Derm Venereol (2019) 0.75
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis. Eur J Dermatol (2012) 0.75
Analysis of immunoglobulin variable kappa gene mutations in cutaneous B-cell lymphoma. J Dermatol Sci (2007) 0.75
Squamous cell carcinoma. Cancer Treat Res (2009) 0.75
Analysis of p53 polymorphisms in individuals with multiple melanocytic nevi. Eur J Dermatol (2013) 0.75
Exacerbation of a Primary Follicular Centre Cutaneous B-cell Lymphoma during Pregnancy and Resolution to Anetoderma After Delivery. Acta Derm Venereol (2016) 0.75
Clinical tip: use of a manual dermatoscope with a compact digital camera in a pigmented lesion clinic. Skin Res Technol (2009) 0.75
Incidence and clinical predictors of primary opportunistic deep cutaneous mycoses in solid organ transplant recipients: a multicenter cohort study. Clin Transplant (2009) 0.75
Dermoscopic features of eruptive melanocytic naevi in an adult patient receiving immunosuppressive therapy for Crohn's disease. Melanoma Res (2005) 0.75
Acne keloidalis of the scalp in a renal transplant patient treated with cyclosporine. Acta Derm Venereol (2009) 0.75
A Case of Angioinvasive Cutaneous Anaplastic Large Cell Lymphoma Completely Regressed After Low-dose Systemic Methotrexate. Acta Derm Venereol (2017) 0.75
Pustular eruption associated with granulocyte colony-stimulating factor treatment. G Ital Dermatol Venereol (2016) 0.75
Effects of TNF-alpha inhibitors on the number of epidermal Langerhans cells in uninvolved skin of psoriatic patients: a pilot study. Acta Histochem (2013) 0.75
Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers. Eur J Dermatol (2011) 0.75
Contribution of susceptibility gene variants to melanoma risk in families from the Veneto region of Italy. Pigment Cell Melanoma Res (2011) 0.75
TNF blockade and cutaneous lupus erythematosus: where do we stand and where are we going? Immunotherapy (2013) 0.75
Meyerson's phenomenon in a patient affected by high-risk melanoma under treatment with interferon-α. Melanoma Res (2012) 0.75